HYD Stock Overview
Hydrix Limited provides product design, engineering, and regulatory services in Australia, Singapore, Europe, North America, and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
My Notes
NewNotes are coming soon
Hydrix Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.054 |
52 Week High | AU$0.14 |
52 Week Low | AU$0.047 |
Beta | 1.98 |
1 Month Change | 8.00% |
3 Month Change | -15.63% |
1 Year Change | -58.46% |
3 Year Change | -75.45% |
5 Year Change | -95.50% |
Change since IPO | -98.94% |
Recent News & Updates
Shareholder Returns
HYD | AU Electronic | AU Market | |
---|---|---|---|
7D | -1.8% | -2.3% | 0.3% |
1Y | -58.5% | -47.2% | 1.4% |
Return vs Industry: HYD underperformed the Australian Electronic industry which returned -47.2% over the past year.
Return vs Market: HYD underperformed the Australian Market which returned 1.4% over the past year.
Price Volatility
HYD volatility | |
---|---|
HYD Average Weekly Movement | 9.8% |
Electronic Industry Average Movement | 8.6% |
Market Average Movement | 8.5% |
10% most volatile stocks in AU Market | 15.7% |
10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: HYD is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: HYD's weekly volatility (10%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1993 | 70 | n/a | https://www.hydrix.com |
Hydrix Limited provides product design, engineering, and regulatory services in Australia, Singapore, Europe, North America, and internationally. It operates through two segments: Hydrix Services and Hydrix Medical. It provides cardiovascular products, such as The GUARDIAN, a cardiac monitoring and alerting device that reduces the stresses of living; Phyzhon PHYRARI FFR-Wire enables cardiologists to combine diagnosis procedures with delivery of therapy including stents; and LUDO, a customizable plug-and-play platform that provides critical tools to start MCS pump development.
Hydrix Limited Fundamentals Summary
HYD fundamental statistics | |
---|---|
Market Cap | AU$13.73m |
Earnings (TTM) | -AU$5.55m |
Revenue (TTM) | AU$10.46m |
1.3x
P/S Ratio-2.5x
P/E RatioIs HYD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HYD income statement (TTM) | |
---|---|
Revenue | AU$10.46m |
Cost of Revenue | AU$1.75m |
Gross Profit | AU$8.71m |
Other Expenses | AU$14.26m |
Earnings | -AU$5.55m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.022 |
Gross Margin | 83.28% |
Net Profit Margin | -53.03% |
Debt/Equity Ratio | 70.0% |
How did HYD perform over the long term?
See historical performance and comparison